In the United States, where reprocessing has been regulated for over a decade, a number of different sources have confirmed the significant cost-savings hospitals achieve through reprocessing select “single-use” medical devices (SUDs). Hospitals not only save about 50% for every reprocessed device they purchase and spend less on waste disposal, they also…
AMDR’s “best clinical practice” document provides information on reprocessing including legal, regulatory and historic details and how SUD reprocesing has become a best practice for most American hospitals.
Most hospitals reprocess single-use devices (SUDs) to maximize savings and divert medical waste from landfills. Some device companies bundle new and reprocessed SUDs as ‘comprehensive or circular device programs,’ claiming to offer consistent, predictable supply and pricing. However, these bundled programs can negatively impact your savings and waste reduction potential.
The U.S. Food and Drug Administration issued a recall of reprocessed Agilis Steerable Introducers from SterilMed, a unit of Johnson & Johnson, on product lots manufactured between January 1 and May 5, 2017. Agilis Introducer Sheaths reprocessed by AMDR member companies Innovative Health, Stryker Sustainability Solutions and Vanguard AG are NOT the subject of this recall and remain on the market.